Evidence indicates that AnxA1 may also play an important role in tumor development and progression, with AnxA1 levels being up- and down-regulated in different cancers, e.g., the loss of AnxA1 expression in prostate cancer correlates with an early onset of tumorigenesis (Xin et al., 2003). This evidence concerns the gene ANXA1 and prostate carcinoma.